RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2011; 105(06): 1124
DOI: 10.1160/TH11-02-0120
DOI: 10.1160/TH11-02-0120
Letters to the Editor
Reasons for aspirin resistance
Authors
Weitere Informationen
Publikationsverlauf
Received:
22. Februar 2011
Accepted after minor revision:
09. März 2011
Publikationsdatum:
28. November 2017 (online)
-
References
- 1 Szczeklik A, Musial J, Undas A. et al. Aspirin resistance. J Thromb Haemost 2005; 3: 1655-1662.
- 2 Henry P, Vermillet A, Boval B. et al. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease. Thromb Haemost 2011; 105: 336-344.
- 3 Lordkipanidze M. Why an aspirin a day no longer keeps the doctor away …. Thromb Haemost 2011; 105: 209-210.
- 4 Szczeklik A, Musial J, Undas A. et al. Inhibition of thrombin generation by aspirin is blunted in hyper-cholesterolemia. Arterioscler Thromb Vasc Biol 1996; 16: 948-954.
- 5 Undas A, Brummel KE, Musial J. et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 2001; 103: 2248-2253.
- 6 Szczeklik A, Dropinski J, Radwan J. et al. Persistent generation of thrombin after acute myocardial infarction. Arterioscler Thromb Vasc Biol 1992; 12: 548-553.
- 7 Merlini PA, Bauer KA, Oltrona L. et al. Persistent activation of coagulation mechanism in unstable an-gina and myocardial infarction. Circulation 1994; 90: 61-68.
- 8 Grove EL, Hvas AM, Johnsen HL. et al. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost 2010; 103: 1245-1253.
- 9 Goodman T, Ferro A, Sharma P. Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Br J Clin Pharmacol 2008; 66: 222-232.
- 10 Nurden AT. Platelet glycoprotein IIIa polymorphism and coronary thrombosis. Lancet. 1997; 350: 1189-1191.
- 11 Undas A, Sanak M, Musial J. et al. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet 1999; 353: 982-983.
- 12 Szczeklik A, Undas A, Sanak M. et al. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 2000; 110: 965-967.